06.27.2024  Celsius Therapeutics (President and CEO: Tariq Kassum, MD; Headquarters: Cambridge, USA), has been acquired by AbbVie, a global leader in biopharmaceuticals. Under the terms of the agreement, AbbVie has acquired all outstanding equity of Celsius Therapeutics for a total of $250 million in cash, subject to customary adjustments.  View the original press release here: … Continue reading AbbVie Acquires Celsius Therapeutics